These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4597977)

  • 1. Effect of triterpenoids related to carbenoxolone upon human pepsins and pepsinogens and upon bovine trypsin and chymotrypsin.
    Waft LA; Roberts NB; Taylor WH
    Clin Sci Mol Med; 1974 Apr; 46(4):519-26. PubMed ID: 4597977
    [No Abstract]   [Full Text] [Related]  

  • 2. The inactivation by carbenoxolone of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci Mol Med; 1973 Aug; 45(2):213-24. PubMed ID: 4206390
    [No Abstract]   [Full Text] [Related]  

  • 3. The inhibition by carbenoxolone sodium of individual human pepsinogens and pepsins.
    Roberts NB; Taylor WH
    Clin Sci; 1973 Feb; 44(2):6P-7P passim. PubMed ID: 4579239
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of carbenoxolone on ionic fluxes across normal gastric mucosa and that associated with gastric ulcer.
    Ivey KJ; Gray C
    Aust N Z J Med; 1973 Oct; 3(5):451-6. PubMed ID: 4591118
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of cyclo-alkyl lactamimides upon human pepsins and pepsinogens.
    Roberts NB; Taylor WH
    Clin Sci Mol Med; 1978 Feb; 54(2):181-5. PubMed ID: 340116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitors of pepsin, trypsin and chymotrypsin in seeds of plants consumed by humans and animals. I. Evaluation of pepsin, trypsin, and chymotrypsin inhibitors activity in seeds of 26 plant species.
    Bańkowska A; Roszkowska-Jakimiec W; Worowski K
    Rocz Akad Med Bialymst; 1998; 43():278-86. PubMed ID: 9972064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of trichloroacetate ion on the proteolytic activity of chymotrypsin, trypsin & pepsin.
    Sagar AJ; Premsagar KD; Rao MS
    Indian J Biochem Biophys; 1972 Mar; 9(1):52-4. PubMed ID: 4565918
    [No Abstract]   [Full Text] [Related]  

  • 8. Editorial: Carbenoxolone sodium and peptic ulcer.
    Med J Aust; 1974 Dec; 2(26):916-7. PubMed ID: 4453278
    [No Abstract]   [Full Text] [Related]  

  • 9. Pepsins, peptic activity, and peptic inhibitors.
    Samloff IM
    J Clin Gastroenterol; 1981; 3(Suppl 2):91-4. PubMed ID: 6119339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of carbenoxolone on enzymes and their relation to its therapeutic effect.
    Roberts NB; Taylor WH
    Scand J Gastroenterol Suppl; 1980; 65():11-7. PubMed ID: 6782651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric ulcer under modern medical management.
    Montgomery RD
    J R Coll Physicians Lond; 1977 Jan; 11(2):181-94. PubMed ID: 320328
    [No Abstract]   [Full Text] [Related]  

  • 12. Carbenoxolone sodium.
    Sircus W
    Gut; 1972 Oct; 13(10):816-24. PubMed ID: 4564085
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of peptic activity by carbenoxolone and glycyrrhetinic acid.
    Henman FD
    Gut; 1970 Apr; 11(4):344-51. PubMed ID: 4913800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-protease activity of amylopectin sulfate].
    Ishii Y; Furuta Y; Tanaka T; Minowa M
    Nihon Yakurigaku Zasshi; 1974 Jul; 70(4):507-14. PubMed ID: 4613634
    [No Abstract]   [Full Text] [Related]  

  • 15. Reversible inactivation of the potential pepsin activity of pepsinogen by alcohols.
    Neumann H; Shinitzky M
    Biochemistry; 1971 Nov; 10(23):4335-42. PubMed ID: 5001736
    [No Abstract]   [Full Text] [Related]  

  • 16. Letter: Complications of carbenoxolone therapy.
    Br Med J; 1974 Sep; 3(5934):804. PubMed ID: 4414160
    [No Abstract]   [Full Text] [Related]  

  • 17. Carbenoxolone sodium in the treatment of peptic ulcer. A review.
    Lewis JR
    JAMA; 1974 Jul; 229(4):460-2. PubMed ID: 4600402
    [No Abstract]   [Full Text] [Related]  

  • 18. Bovine pepsinogens and pepsins. A series of zymogens and enzymes that differ in organic phosphate content.
    Meitner PA; Kassell B
    Biochem J; 1971 Jan; 121(2):249-56. PubMed ID: 4940473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: The effects of aspirin, carbenoxolone, and gefarnate on the gastric mucosal potential difference in man.
    Hossenbocus A; Colin-Jones DG
    Gut; 1974 Apr; 15(4):335-6. PubMed ID: 4834559
    [No Abstract]   [Full Text] [Related]  

  • 20. Peptic ulcer: medical treatment.
    Langman MJ
    Br Med J; 1969 Oct; 4(5675):100-2. PubMed ID: 4898560
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.